Circulating Tumor DNA Testing Opens New Perspectives in Melanoma Management

Malignant melanoma accounts for about 1% of all skin cancers, but it causes most of the skin cancer-related deaths. Circulating tumor DNA (ctDNA) testing is emerging as a relevant tool for the diagnosis and monitoring of cancer. The availability of highly sensitive techniques, including next generat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Alessandra Sacco, Laura Forgione, Marianeve Carotenuto, Antonella De Luca, Paolo A. Ascierto, Gerando Botti, Nicola Normanno
Format: Artigo
Idioma:Inglês
Publicat: MDPI AG 2020-10-01
Col·lecció:Cancers
Matèries:
ctDNA
melanoma
liquid biopsy
prognosis
prediction
patient stratification
Accés en línia:https://www.mdpi.com/2072-6694/12/10/2914
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars